Bayer, Sandoz, and Viatris labs' progress hailed as significant by Veronique, an affected individual (Androcur).
Freed from a seven-year-long fight, Veronique Dujardin claims victory in the Androcur scandal as three pharmaceutical labs face conviction on June 2, 2021, in Poitiers (Vienne). The court's ruling acknowledges a link between her brain tumors and the drug she consumed for two decades.
Bayer challenges the verdict
It's a massive relief, not just legally, but psychologically too," says Veronique Dujardin, beaming with relief. The entities Bayer, Sandoz, and Viatris have been ordered to fork over €300,000 due to withheld information. From 1991 to 2013, Veronique unwittingly devoured Androcur or its generic counterparts to rectify a hormonal imbalance. Over time, she experienced worsening vision loss and was ultimately diagnosed with three meningiomas, non-cancerous tumors that wreak havoc on the nervous system. This, along with various serious side effects, were apparently not broached in any conversation with her, despite similar cases cropping up in the 2000s. Bayer plans to lodge an appeal against the decision.
Catch the whole scoop in the video above
- Veronique Dujardin's victory in the Androcur scandal underscores the critical link between science and health-and-wellness, as her medical-conditions were caused by the drug she consumed.
- Despite the court's ruling, Bayer, Sandoz, and Viatris, major players in science and therapies-and-treatments, are set to challenge the verdict, placing mental-health concerns of victims on hold.
- The Androcur scandal serves as a sobering reminder of the importance of transparency in the medical field, especially when discussing side effects and potential risks associated with cancer treatments.
.){kind=link}